NCT00100906 2013-08-16Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed18 enrolled